EOS Hellenic Renaissance Fund II (EHRF II) invests in Seneca Medical Group
EOS Capital Partners announces third investment, through the fund EOS Hellenic Renaissance Fund 2 (“EHRF 2”), in Seneca Medical Group (“Seneca”), a pioneer in the field of hair transplantation, with the aim of creating the leading platform in the sector across Europe and the Middle East.
About Seneca Medical Group
Seneca Medical Group is one of the most innovative and rapidly growing companies in the field of hair transplantation in Europe. With an emphasis on scientific evidence, personalized patient care, and the implementation of advanced medical protocols, Seneca provides high-level services exclusively through certified doctors. The company operates in Greece, the United Kingdom, Denmark and Romania and continues its growth trajectory through strategic partnerships and international expansion.
George Kottaridis, founder and CEO of Seneca, will assume the CEO role under the new investment structure, leading the delivery of the shareholders’ joint investment plan.
By combining the long-standing experience of its founding members with Seneca’s modern approach and technological innovation, the new group aims to set new standards in quality, safety and customer satisfaction, while at the same time strengthening its international orientation through investments in medical tourism and international expansion.
George Kottaridis, Founder and CEO of Seneca, stated: “Today’s announcement marks a particularly important milestone for Seneca Medical Group. Our collaboration with EHRF 2 is not simply a strategic move – it is a powerful alliance of shared goals and values.
At Seneca Medical Group we have already reached the top as the No. 1 hair transplantation clinic in Greece, and we continue with the same determination to evolve. Through this partnership, we enhance our ability to provide better, more personalized and more effective services to every person who places their trust in us.
At the same time, the support of EHRF 2 allows us to invest even more dynamically in the future: in growth, in research, in technology and – above all – in our patients’ experience. Our commitment remains steadfast: to deliver the most comprehensive and scientifically proven solutions in the field of hair restoration, with respect, responsibility, and care.
I am particularly proud of this new partnership, and I look forward to what we will achieve together.”
Nicholas Chryssanthopoulos, Senior Partner at EOS Capital Partners, stated:
“Our investment in Seneca marks the creation of a strong business platform with significant prospects for further growth in the European and international hair transplantation market. Hair restoration has now advanced significantly in terms of technology, medical expertise, and customer experience, and we believe that Greek companies and doctors are among the best worldwide. We are very excited about this new chapter for Seneca.”
About EOS
EOS is the external Alternative Investment Fund Manager of EHRF II, a private equity fund with 219m in AUM, focusing on growth capital investments in Greek SMEs across all sectors.
EOS investment strategy focuses on SMEs with a healthy financial position and a solid value proposition looking for capital to achieve their growth potential either organically or inorganically through mergers and acquisitions.
